The ITIM-Containing Receptor: Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) Modulates Immune Response and Confers Poor Prognosis in Invasive Breast Carcinoma

SIMPLE SUMMARY: Breast cancer exhibits significant genetic and clinical heterogeneity. Given the importance of understanding tumour-immune interactions to enable the development of novel immunotherapies, identification of novel prognostic biomarkers is important for accurate predictions of the breas...

Descripción completa

Detalles Bibliográficos
Autores principales: Joseph, Chitra, Alsaleem, Mansour A., Toss, Michael S., Kariri, Yousif A., Althobiti, Maryam, Alsaeed, Sami, Aljohani, Abrar I., Narasimha, Pavan L., Mongan, Nigel P., Green, Andrew R., Rakha, Emad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795350/
https://www.ncbi.nlm.nih.gov/pubmed/33396670
http://dx.doi.org/10.3390/cancers13010080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795350/
https://www.ncbi.nlm.nih.gov/pubmed/33396670
http://dx.doi.org/10.3390/cancers13010080

Ejemplares similares